Antidepressants and Psychotherapy: A Clinical Research Review

University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic PA 15213, USA.
Dialogues in clinical neuroscience 02/2005; 7(3):263-72. DOI: 10.1176/foc.4.4.581
Source: PubMed

ABSTRACT This review focuses on information concerning antidepressants and psychotherapy in the treatment of both acute and chronic forms of unipolar depression in the English language literature. In it, we address the use of combination therapy, both from the outset of treatment and in a variety of sequences, ie, we examine the potential advantages of adding a targeted psychotherapy to an incompletely effective pharmacotherapy and the potential advantages of adding pharmacotherapy to an incompletely effective psychotherapy. The number of research reports available to address these questions is small relative to their importance for clinical practice. There is a clear need for more information about the relative efficacy of pharmacotherapy-psychotherapy combinations or sequences versus either pharmacotherapy or psychotherapy provided as monotherapies.

Download full-text


Available from: Danielle Novick, Sep 28, 2015
29 Reads
    • "Mother and child are cared for together. Medication and psychotherapy for the mother are most often both offered because this is considered the optimal treatment available (Frank et al., 2005). When emergency intervention is the first contact with the patient, it is followed by an offer for therapeutic care and follow-up, either with the same team when the patient resides in the catchment area or within another available program. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pregnancy is the time during which physiological and psychological preparation for motherhood takes place. It has long been considered a blessed time, free of psychiatric disorders. However, there is now strong evidence that major depressive disorder may occur not only after birth but even during the prepartum. Most often, mental illness during this period is underestimated, not assessed, therefore not diagnosed, and consequently goes untreated. Reviewing the literature on the negative impact of both maternal and infant health in case of perinatal depression, we underline that recognizing and treating prenatal depression will lead to preventive and curative treatments for mothers, enhance infant health, and therefore positively influence mother-infant relationships.
    The Journal of nervous and mental disease 08/2011; 199(8):575-7. DOI:10.1097/NMD.0b013e318225f2f4 · 1.69 Impact Factor
  • Source
    • "combination of antidepressant drugs and psychotherapy compared to drug alone (Frank et al., 2005 ; Kupfer and Frank, 2001 ; Middleton et al., 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite limited understanding of the pathophysiology of depression and the underlying mechanisms mediating antidepressant effects, there are several efficient treatments. The anhedonia symptoms of depression are characterized by decreased motivation and drive and imply possible malfunctioning of the mesolimbic dopamine system, whereas cognitive deficits might reflect decreased plasticity in hippocampus. In female Flinders Sensitive Line (FSL) rats, a model of depression, we compared the effects of three long-term antidepressant treatments: voluntary running, escitalopram and the combination of both on antidepressant-like behaviour in the Porsolt swim test (PST), and on regulation of mRNA for dopamine and neuropeptides in striatal dopamine pathways and brain-derived neurotrophic factor (BDNF) in hippocampus. Escitalopram diet attenuated running behaviour in FSL rats but not in non-depressed controls rats. In the PST the running group had increased climbing activity (noradrenergic/dopaminergic response), whereas the combination of escitalopram and running-wheel access increased swimming (serotonergic response). Running elevated mRNA for dynorphin in caudate putamen and BDNF in hippocampus. The combined treatment down-regulated D1 receptor and enkephalin mRNA in accumbens. Escitalopram alone did not affect behaviour or mRNA levels. We demonstrate a novel behavioural effect of escitalopram, i.e. attenuation of running in 'depressed' rats. The antidepressant-like effect of escitalopram was dependent on the presence of a running wheel, but not actual running indicating that the environment influenced the antidepressant effect of escitalopram. Different patterns of mRNA changes in hippocampus and brain reward pathways and responses in the PST by running and escitalopram suggest that antidepressant-like responses by running and escitalopram are achieved by different mechanisms.
    The International Journal of Neuropsychopharmacology 07/2008; 11(8):1135-47. DOI:10.1017/S1461145708008912 · 4.01 Impact Factor
  • Source
Show more